awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633F
Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633F
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
P2860
Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37282589-FE6F5C52-AB62-4292-B96A-03E4807D633F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a7fdc517075d4116bafa3ed03479e8ca3b66f4cb
P2860
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.